CELL SIGNALING TECHNOLOGY
Live / Registered — Registered and renewed (as of 03 Sept 2021)
What this means for you
Registered since 10 May 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 May 2021).
Record
- Serial number
- 85012071
- Registration number
- 3956946
- Mark type
- Stylized text
- Filed
- 12 Apr 2010
- Published for opposition
- 22 Feb 2011
- Registered
- 10 May 2011
- Next maintenance due
- 10 May 2021
- Attorney of record
- Keith A. Weltsch, Esq.
Goods and services
- Class 001 — Chemicals: Antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors designed for use in biotechnological and biomedical research
Owner
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
Prior registrations
Prosecution history
- 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Sept 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Sept 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Sept 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 May 2021 — TEAS SECTION 8 & 9 RECEIVED
- 10 May 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Feb 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Feb 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Nov 2016 — TEAS SECTION 8 & 15 RECEIVED
- 10 May 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED